Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous natural killer cells SNK01

A preparation of autologous, ex-vivo expanded and activated natural killer (NK) cells, with potential cytolytic and antineoplastic activities. Upon infusion back into the patient, the autologous NK cells SNK01 may lyse cancer cells. These cells also secrete pro-inflammatory cytokines, which further stimulate an anti-tumor immune response.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	autologous NK cells SNK01 autologous NKCs SNK01
Code name:	SNK 01 SNK-01 SNK01

autologous natural killer cells SNK01

Search NCI's Drug Dictionary